- Report
- August 2025
- 197 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- July 2025
Global
From €4314EUR$4,799USD£3,744GBP
- Report
- September 2025
- 540 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- September 2025
- 328 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- May 2025
- 740 Pages
Global
From €4449EUR$4,950USD£3,862GBP
- Report
- July 2025
Global
From €4404EUR$4,900USD£3,823GBP
- Report
- May 2025
- 139 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- April 2025
- 139 Pages
Global
From €3595EUR$3,999USD£3,120GBP
- Report
- June 2025
- 200 Pages
Global
From €2238EUR$2,490USD£1,943GBP
- Report
- December 2025
- 270 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- October 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- August 2025
- 150 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- June 2025
- 100 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- May 2025
- 190 Pages
Global
From €5348EUR$5,950USD£4,643GBP
- Report
- January 2026
- 183 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 186 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 189 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 198 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 192 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP

The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more